Table 1

Clinical characteristics of study patients

PatientAgeSexFEV1 (% pred)PC20 hist (mg/ml)Skin test*RhinitisMedication asthmaMedication rhinitis
*X times histamine reaction.
B=beclomethasone or budesonide; F=fluticasone; SB=salbutamol; SM=salmeterol; FO=formeterol.
Placebo group
121M971.762.1B, SB
211M790.741.1+B, SB
311M974.001.4+B, SB
429M810.331.2F, SM
521M732.432.0+B, SBB
627F700.901.2+B, SBB
744M701.891.2+F, SMF
817F1381.781.9+B
940M641.131.6+B, SB
1029M1030.711.5+
1128F730.452.2F, SB
1212M1064.001.6+B, SB
1325F981.531.5+SB
1430M1002.901.5B, SB
Mean25891.751.6
SD10201.210.4
Active group
125F991.191.5+B, SB
229M990.951.6B
341M673.792.2+B, SB
424F862.001.8+B, SB
531M811.221.5
624M800.551.1+B, SBB
722F1042.671.4+B
851F700.451.2+B, SBB
932M680.421.1B, SM
1036F1030.351.8+SBB
1142M750.421.2B, SM
1218F1032.351.2+F, SMF
1340F980.861.6+B, SBB
1430F1071.161.9+F, SBF
1541F970.981.1B, SM
1637M760.911.3SB
Mean33881.271.5
SD9140.970.3